Hydrogen Peroxide 40%
DrugTopical hydrogen peroxide 40 percent w/w solution in opaque light-protected applicator bottle applied once weekly for up to 12 weeks
NCT Number: NCT07830979
This randomized controlled trial aims to compare the efficacy and safety of topical hydrogen peroxide 40 percent versus topical salicylic acid 40 percent in the treatment of plantar warts.
Trial opening soon.
Get Notified12 year and older
All sexes
Interventional
Phase 3
Plantar warts are common benign lesions caused by human papillomavirus on weight-bearing areas causing pain and functional impairment. This is a randomized parallel assignment study conducted at the Outpatient Dermatology Clinic Assiut University Hospital. Eligible patients with clinically diagnosed plantar warts will be randomized in 1 to 1 ratio to topical hydrogen peroxide 40 percent applied once weekly by physician or topical salicylic acid 40 percent self-applied once daily. Treatment duration 12 weeks with assessments every 2 weeks including measurement size photographs clearance status adverse effects compliance and satisfaction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Topical hydrogen peroxide 40 percent w/w solution in opaque light-protected applicator bottle applied once weekly for up to 12 weeks
Topical salicylic acid 40 percent w/w preparation applied once daily for up to 12 weeks
Time frame: At 12 weeks
Number of participants with complete clinical clearance defined as complete disappearance of plantar wart and restoration of normal skin markings
Time frame: Up to 12 weeks
Time in weeks from treatment start to complete clinical clearance
Time frame: From baseline to 12 weeks
Change in wart surface area in square millimeters measured in two perpendicular diameters using digital caliper from baseline
Time frame: Up to 12 weeks
Pain score assessed using 0 to 10 Visual Analogue Scale with 0 indicating no pain and 10 indicating worst pain with higher scores indicating worse pain
Time frame: Up to 12 weeks
Number of participants who develop local adverse effects including blistering hyperpigmentation scarring or secondary infection
Time frame: At 12 weeks
Patient satisfaction assessed using 0 to 10 satisfaction scale with higher scores indicating greater satisfaction
Time frame: Up to 12 weeks
Number of participants with recurrence of plantar warts after initial complete clearance
Contact information is provided by the study sponsor or research team.
Assiut University
Other
Topical Hydrogen Peroxide 40% Versus Salicylic Acid 40% in the Treatment of Plantar Warts: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03977753
Common Wart, DNA Virus Infections
Bouge, Belgium
View Trial DetailsNCT07448844
Common Wart, Common Warts (Verruca Vulgaris)
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT07197541
Plantar Wart
Hangzhou, Zhejiang, China
View Trial DetailsNCT06214559
Common Wart, DNA Virus Infections
Tunis, Tunisia
View Trial Details